DISPENSING OF BIOLOGICS PRESCRIBED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE AUSTRALIAN POPULATION

被引：1
|
作者：
Jones, G. [1 ]
Bird, P. [2 ]
Hall, S. [3 ]
Littlejohn, G. [4 ]
Tymms, K. [5 ]
Youssef, P. [6 ]
Chung, E. [7 ]
Bennett, C. [8 ]
Button, P. [8 ]
机构：
[1] Royal Hobart Hosp, Hobart, Tas, Australia
[2] Combined Rheumat Practice, Kogarah, NSW, Australia
[3] Cabrini Med Ctr, Malvern, Vic, Australia
[4] Monash Med Ctr, Clayton, Vic, Australia
[5] Canberra Rheumatol, Canberra, ACT, Australia
[6] Royal Prince Alfred Hosp, Camperdown, NSW, Australia
[7] Prospection, Eveleigh, NSW, Australia
[8] Roche Prod Pty Ltd, Dee Why, NSW, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4326
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0146
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [41] A dancer with rheumatoid arthritis: a role for biologics
    H. A. Bird
    A. Bergstrom
    Clinical Rheumatology, 2013, 32 : 507 - 509
  • [42] Biologics and Mortality Risk in Rheumatoid Arthritis - Results of a Population Based Study.
    Lacaille, Diane
    Abrahamowicz, Michal
    Sayre, Eric C.
    Esdaile, John
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S701 - S702
  • [43] Clinical trials on biologics in rheumatoid arthritis
    Sander, O
    Rau, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (11) : 621 - 624
  • [44] Biologics and Mortality Risk in Rheumatoid Arthritis - Results of a Population-based Study
    Lacaille, Diane
    Sayre, Eric
    Abrahamowicz, Michal
    Esdaile, John
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 966 - 967
  • [45] Effect of Biologics on the Hemoglobin A1c in a Population of Rheumatoid Arthritis Patients
    Goico, Ana
    Martis, Anoka
    Kabir, Chistopher
    Mael, David
    Mohammed, Shoeb
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] EVOLUTION OF REGULATORY B CELLS UNDER TREATMENT BY BIOLOGICS IN RHEUMATOID ARTHRITIS
    Salomon, S.
    Guignant, C.
    Brault, C.
    Flahaut, G.
    Gubler, B.
    Fardellone, P.
    Marolleau, J.
    Goeb, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 905 - 905
  • [47] COVERAGE OF BIOLOGICS FOR RHEUMATOID ARTHRITIS IN CANADA
    Vannabouathong, C.
    Le, K.
    Dyrda, P.
    VALUE IN HEALTH, 2023, 26 (06) : S236 - S236
  • [48] The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review
    Joensuu, Jaana T.
    Huoponen, Saara
    Aaltonen, Kalle J.
    Konttinen, Yrjo T.
    Nordstrom, Dan
    Blom, Marja
    PLOS ONE, 2015, 10 (03):
  • [49] TIPS ON SELECTION OF BIOLOGICS FOR PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON TREATMENT PATTERNS
    Kamiya, M.
    Seen, S.
    Kikuchi, H.
    Okada, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1137 - 1137
  • [50] A NETWORK METANALYSIS COMPARING THE EFFICACY OF BIOLOGICS FOR THE TREATMENT OF EARLY RHEUMATOID ARTHRITIS
    Bizzi, E.
    Petrella, L.
    Integlia, D.
    Migliorc, A.
    VALUE IN HEALTH, 2015, 18 (07) : A636 - A636
12345